Article
Challenges and prospects of cell-free DNA in precision oncology
2024-11-09
Abstract excerpt
Cell-free DNA (cfDNA), predominantly derived from apoptotic or necrotic cells, is emerging as a potential biomarker due to non-invasiveness and cost-effectiveness 1 . Additionally, another type of cfDNA such as cell-free mitochondrial DNA (cf-mtDNA) that is released from cells under stress or damage condition, may play a key role in the immune system. Thus, the presence of cfDNA in the circulation of cancer patien...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 53710e79-26e2-58fc-97ec-a9c4378a14eb
- DOI
- 10.1016/j.medp.2024.100059
